Biodistribution of [111In-DTPA-D-Phe1]-octreotide in dogs: Uptake in the stomach and intestines but not in the spleen points towards interspecies differences

Nuclear Medicine and Biology

Volumn 30, Issue 3, 2003, Pages 225-232

  Robben, Joris ^a   Reubi, Jean Claude ^b   Pollak, Yvonne ^a   Voorhout, George ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Biodistribution; Dog; Somatostatin receptor scintigraphy; 111In DTPA D Phe1 octreotide

Indexed keywords

OCTREOTIDE[3 TYROSINE] I 125; PENTETREOTIDE IN 111; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DRUG DERIVATIVE; OCTREOTIDE; PENTETIC ACID; SDZ 215 811; SDZ 215-811;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOG; GASTROINTESTINAL TRACT; IN VITRO STUDY; INTESTINE; NERVE PLEXUS; NONHUMAN; PEYER PATCH; RADIOACTIVITY; SAMPLING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLEEN; STOMACH; TISSUE DISTRIBUTION; ANIMAL; INTRAVENOUS DRUG ADMINISTRATION; MALE;

ANIMALS; AUTORADIOGRAPHY; DOGS; INJECTIONS, INTRAVENOUS; MALE; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0042853173     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(02)00441-9     Document Type: Article

References (35)

1. Altschul M., Simpson K.W., Dykes N.L., Mauldin E.A., Reubi J.C., Cummings J.F. Evaluation of somatostatin analogues for the detection and treatment of gastrinoma in a dog. J Small Anim Pract. 38:1997;286-291.
2. 1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors synthesis, radiolabeling and in vitro validation . Life Sci. 49:1991;1583-1591.
3. Bakker W.H., Krenning E.P., Breeman W.A., Kooij P.P.M., Reubi J.-C., Koper J.W., de Jong M., Laméris J.S., Visser T.J., Lamberts S.W. In vivo use of radioiodinated somatostatin analogue dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man . J Nucl Med. 32:1991;1184-1189.
4. Bakker W.H., Krenning E.P., Breeman W.A., Koper J.W., Kooij P.P., Reubi J.-C., Klijn J.G., Visser T.J., Docter R., Lamberts S.W. Receptor scintigraphy with a radioiodinated somatostatin analogue radiolabeling, purification, biological activity, and in vivo applications in animals . J Nucl Med. 31:1990;1501-1509.
5. 1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci. 49:1991;1593-1601.
6. 3 derivatives of octreotide in rats. Anticancer Res. 18:1998;83-90.
7. 1]octreotide . Eur J Nucl Med. 21:1994;328-335.
8. 0]octreotide . Eur J Nucl Med. 25:1998;182-186.
9. 111In-labelled octreotide derivatives . Eur J Nucl Med. 27:2000;1318-1325.
10. 3]octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy. Int J Cancer. 75:1998;406-411.
11. 1-octreotide by isolated perfused rat liver. J Nucl Med. 34:1993;2025-2030.
12. DelValle J., Park J., Chiba T., Yamada T. Cellular mechanisms of somatostatin action in the gut. Metabolism. 39:(suppl 2):1990;134-137.
13. Duncan J.R., Stephenson M.T., Wu H.P., Anderson C.J. Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes. Cancer Res. 57:1997;659-671.
14. Krausz Y., Shibley N., de Jong R.B.J., Yaffe S., Glaser B. Gallbladder visualization with In-111 labeled octreotide. Clin Nucl Med. 19:1994;133-135.
15. Krenning E.P., Bakker W.H., Kooij P.P.M., Breeman W.A.P., Oei H.Y., de Jong M., Reubi J.C., Visser T.J., Bruns C., Kwekkeboom D.J., Reijs A.E.M., van Hagen P.M., Koper J.W., Lamberts S.W.J. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide . J Nucl Med. 33:1992;652-658.
16. Krenning E.P., Breeman W.A.P., Kooij P.P.M., Lameris J.S., Bakker W.H., Koper J.W., Ausema L., Reubi J.C., Lamberts S.W.J. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet. 1:1989;242-244.
17. Krenning E.P., Kooij P.P.M., Pauwels S., Breeman W.A.P., Postema P.T.E., de Herder W.W., Valkema R., Kwekkeboom D.J. Somatostatin receptor scintigraphy and radionuclide therapy . Digestion. 57:(suppl 1):1996;57-61.
18. 3]-octreotide the Rotterdam experience with more than 1000 patients . Eur J Nucl Med. 20:1993;716-731.
19. 111In-DTPA-octreotide in the same patients biodistribution, kinetics, organ and tumor uptake . J Nucl Med. 40:1999;762-767.
20. Lamberts S.W.J., Krenning E.P., Reubi J.-C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrinol Rev. 12:1991;450-482.
21. 2 in dogs. Am J Physiol. 272:1997;G1481-G1488.
22. Mitsuma T., Rue N., Kayama M., Izumi M., Adachi K., Ohtake M., Mori Y., Hirooka Y., Nogimori T., Sakai J. Distribution of somatostatin receptor type 2 in the rat immunohistochemical study . Endocr Regulations. 30:1996;67-72.
23. Park J., Chiba T., Yokotani K., DelValle J., Yamada T. Somatostatin receptors on canine fundic D-cells evidence for autocrine regulation of gastric somatostatin . Am J Physiol. 257:1989;G235-G241.
24. Reubi J.C., Horisberger U., Kappeler A., Laissue J.A. Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs. Blood. 92:1998;191-197.
25. Reubi J.C., Horisberger U., Studer U.E., Waser B., Laissue J.A. Human kidney as target for somatostatin high affinity receptors in tubules and vasa recta . J Clin Endocrinol Metab. 77:1993;1323-1328.
26. Reubi J.C., Laissue J., Waser B., Horisberger U., Schaer J.-C. Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tisssues. Ann NY Acad Sci. 733:1994;122-137.
27. Reubi J.C., Waser B., Horisberger U., Krenning E., Lamberts S.W.J., Gebbers J.-O., Gersbach P., Laissue J.A. In vitro autoradiography and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. Blood. 82:1993;2143-2151.
28. Reubi J.C., Waser B., Schaer J.-C., Laissue J.A. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med. 28:2001;836-846.
29. Reubi J.C., Waser B., Schmassmann A., Laissue J.A. Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples where are they really located? Int J Cancer. 81:1999;376-386.
30. Robben J.H., Visser-Wisselaar H.A., Rutteman G.R., van Rijk P.P., van Dongen A.J., Voorhout G., van den Ingh T.S.G.A.M., Hofland L.J., Lamberts S.W.J. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas. J Nucl Med. 38:1997;1036-1042.
31. 2 receptor splice variants in rat gastric mucosa. Cell Tissue Res. 297:1999;163-168.
32. Vallabhajosula S., Moyer B.R., Lister-James J., McBride B.J., Lipszyc H., Lee H., Bastidas D., Dean R.T. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. J Nucl Med. 37:1996;1016-1022.
33. Virgolini I., Szilvasi I., Kurtaran A., Angelberger P., Raderer M., Havlik E., Vorbeck F., Bischof C., Leimer M., Dorner G., Kletter K., Niederle B., Scheithauer W., Smith-Jones P. Indium-111-DOTA-lanreotide biodistribution, safety and radiation absorbed dose in tumor patients . J Nucl Med. 39:1998;1928-1936.
34. 2 receptor-mediated inhibition of parietal cell function in rat isolated gastric mucosa. Brit J Pharmacol. 119:1996;905-910.
35. Yamada Y., Post S.R., Wang K., Tager H.S., Bell G.I., Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci USA. 89:1992;251-255.